The US Centers for Disease Control and Prevention (CDC) has released the latest draft of the Recommendations for HIV Screening in Clinical Settings for public comment. This guideline aims to aid healthcare providers in diagnosing and connecting patients with undiagnosed HIV to clinical care, reestablishing individuals with previously diagnosed HIV in care, detecting HIV infection […]
National Influenza Vaccination Week (NIVW) is a national awareness week dedicated to emphasizing the significance of influenza vaccination. Taking place from December 2-6, 2024, National Influenza Vaccination Week 2024 serves as a timely reminder for individuals aged 6 months and older that there is still an opportunity to receive a flu vaccine this season. Given […]
World AIDS Day is observed annually on December 1st, providing a global platform for individuals to come together in solidarity with those affected by HIV and to honor those who have succumbed to AIDS-related illnesses. Each year, World AIDS Day centers around a specific theme, with this year’s focus being on “Taking the Rights Path.” […]
In recognition of World AIDS Day 2024, our latest edition of the Guidelines+ Monographs Series will delve into the medication bictegravir, emtricitabine, and tenofovir alafenamide, marketed under the brand name Biktarvy® by Gilead Sciences, Inc. Biktarvy is a three-drug combination of bictegravir (BIC), a human immunodeficiency virus type 1 (HIV-1) integrase strand transfer inhibitor (INSTI), […]
Sign up for alerts and stay informed on the latest published guidelines, FDA decisions, and more! Copyright © 2024 Guideline Central, All Rights Reserved.
Sign up for alerts and stay informed on the latest published guidelines, FDA decisions, and more! Copyright © 2024 Guideline Central, All Rights Reserved.
Welcome to this edition of our Guideline Spotlight, where we will delve into the important insights and key takeaways from the comprehensive guideline on the Management of Central Airway Obstruction, developed by The American College of Chest Physicians (CHEST). Central airway obstruction (CAO) is a critical condition that poses a significant threat to life, leading […]
The Food and Drug Administration (FDA) protects public health by guaranteeing the safety, effectiveness, and security of pharmaceuticals and medical devices. The Prescription Drug User Fee Act (PDUFA) date marks the deadline by which the FDA must complete its review of drug applications. Occasionally, an advisory committee (AdCom) meeting is convened to assess the drug […]
The 66th ASH Annual Meeting and Exposition is set to take place from December 7-10, 2024, in San Diego, California, as well as online. This event stands as the premier hematology gathering of the year, attracting over 30,000 health professionals, clinicians, researchers, educators, and other industry experts. Attendees can expect a multitude of sessions, thousands […]
Welcome to the latest edition of our Guideline Spotlight, where we delve into the significant changes and key takeaways from the Centers for Disease Control and Prevention’s (CDC) Adult Immunization Schedule for Ages 19 Years or Older, United States, 2025. This schedule serves as a valuable tool for healthcare providers to determine the recommended vaccines […]
In this edition of our Guideline Spotlight, where we take a look into the significant changes and key takeaways from the Centers for Disease Control and Prevention’s (CDC) Recommended Childhood and Adolescent Immunization Schedule: United States, 2025. This schedule serves as a valuable tool for healthcare providers to determine the recommended vaccines for individuals within […]
The American College of Rheumatology’s annual meeting, ACR Convergence 2024, was held from November 14 to 19 at the Walter E. Washington Convention Center in Washington, D.C. This prestigious event brought together leading experts in the field to exchange the latest advancements in rheumatology. At ACR Convergence 2024, several significant abstracts were presented focusing on […]
In this installment of our Guidelines International Series, we delve into the rich history of the British Association of Dermatologists (BAD), a venerable society established in 1919 by Sir Archibald Gray, then Editor of the British Journal of Dermatology. The BAD’s guiding principle, ‘healthy skin for all’, remains the cornerstone of their mission, although it […]
Ulcerative colitis (UC) impacts nearly 2 million individuals in the United States. This chronic inflammatory bowel disease typically emerges in early adulthood and follows a pattern of relapsing and remitting symptoms. Unfortunately, up to 20% of patients may eventually require colectomy, and 33% may need hospitalization for disease management. Effectively controlling inflammatory activity is essential […]
The American Heart Association’s (AHA) annual meeting, AHA24, was held from November 16-18, 2024, at the McCormick Place Convention Center in Chicago, Illinois. This prestigious event serves as the premier global platform for showcasing the latest advancements in cardiovascular science and medicine, providing attendees with the opportunity to engage with cutting-edge research and practice-changing educational […]
On September 17, 2024, the US Food and Drug Administration (FDA) granted approval for Novartis’s Kisqali® (ribociclib) in combination with an aromatase inhibitor (AI) for the adjuvant treatment of individuals with hormone receptor-positive/human epidermal growth factor receptor 2-negative (HR+/HER2-) stage II and III early cancer (EBC) at high risk of recurrence, including those with node-negative […]
The American Society of Clinical Oncology (ASCO) has announced that the following guideline, “Systemic Treatment of Thyroid Cancer” is now open for public comment. This latest guideline incorporates new evidence to ensure the most current recommendations are provided. As part of ASCO’s development process, they invite reviews and feedback for a 2-to-3-week period. Interested parties […]
Our Guidelines Rundown Series persists with a fresh article delving into the topic of chronic obstructive pulmonary disease (COPD) in recognition of COPD Awareness Month 2024. To aid in clinical decision-making, numerous societies have published extensive guidelines addressing different facets of COPD, such as nutrition management, COPD exacerbations, home oxygen therapy, and more. This article […]
The Urology Care Foundation, the official Foundation of the American Urological Association (AUA), is utilizing the month of November to address the stigma surrounding bladder health issues. Our goal is to provide resources that raise awareness and facilitate conversations between patients and their healthcare providers. In support of Bladder Health Awareness Month 2024, this edition […]
Each November, we commemorate National Epilepsy Awareness Month (NEAM), focusing on educating the public about epilepsy symptoms and supporting research efforts. In honor of NEAM, today’s article will focus on epilepsy. According to the Centers for Disease Control (CDC), between 2021 and 2022, approximately 2.9 million adults aged 18 and older reported experiencing active epilepsy, […]
In the most recent edition of our Guidelines Timeline Series, we explore the American Society of Clinical Oncology’s (ASCO) guideline on Stage IV Non-Small Cell Lung Cancer without Driver Alterations, which was published on February 28, 2024. This guideline was introduced by ASCO as a living document, that is continuously updated to reflect the latest […]
In this edition of our Guideline Spotlight, we will explore the key insights and takeaways from the American Society of Clinical Oncology’s (ASCO) comprehensive guideline, Systemic Therapy for Tumor Control in Metastatic Well-differentiated Gastroenteropancreatic Neuroendocrine Tumors (GEP-NETs). This guideline offers evidence-based recommendations for the treatment of advanced or metastatic GEP-NETs, a rare group of tumors […]
November is National Epilepsy Awareness Month (NEAM), a time dedicated to raising awareness about epilepsy and supporting research efforts. In honor of NEAM, our Guidelines Rundown Series presents a new article focusing on epilepsy. Epilepsy is a well-known condition that affects 1% of adults in the United States. According to the Centers for Disease Control […]
Welcome to the latest edition of our Guidelines+ Monographs Series. In this installment, we will delve into the medication fluticasone furoate, umeclidinium, and vilanterol, marketed under the brand name Trelegy Ellipta by GlaxoSmithKline. Trelegy Ellipta is a combination of fluticasone furoate, an inhaled corticosteroid (ICS); umeclidinium, an anticholinergic; and vilanterol, a long-acting beta2-adrenergic agonist (LABA) indicated […]
November is recognized as National Prematurity Awareness Month, with World Prematurity Day being observed annually on November 17th to raise awareness about preterm birth. The incidence of preterm birth is increasing globally, with an estimated 15 million infants born preterm each year (more than 3 weeks early), as reported by the World Health Organization (WHO). […]